Submit Deal

Submit Deal

Announced

9 May 2023

Completed

9 May 2023

Bionorica completed the acquisition of Lomapharm from Daicel.

Synopsis

Bionorica, a pharmaceutical manufacturer, completed the acquisition of Lomapharm, a pharmaceutical company, from Daicel, a chemical company. Financial terms were not disclosed.

Principals

target

Lomapharm

bidder

BIONORICA

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

Sort

Bidder Team (2)

sz

stephan zuber

Financial Advisor at Baker Tilly

Accountant

bidder

1

Deal

n/a

Total Value

rr

robert rostek

Financial Advisor at Baker Tilly

Accountant

bidder

1

Deal

n/a

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy

Privacy Policy Terms of Service Contact Us Cookie Preferences

All rights reserved. Copyright © 2025 Datasite